PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

Soleus Capital Management, L.P.'s Holding History (CIK: 0001802630)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025

Shares 169,000 Value ($000) $8,173 Avg Close $41.90 Range $33.70 - $60.60

Q4 2024

Shares 275,000 Value ($000) $10,615 Avg Close $43.60 Range $33.31 - $48.89

Q1 2024

Shares 34,500 Value ($000) $998 Avg Close $27.21 Range $21.43 - $33.34

Q4 2023

Shares 83,000 Value ($000) $1,903 Avg Close $17.50 Range $13.72 - $23.88

Q2 2023

Shares 39,800 Value ($000) $1,099 Avg Close $25.03 Range $17.64 - $30.10

Q4 2022

Shares 236,000 Value ($000) $2,575 Avg Close $8.44 Range $7.24 - $11.46

Period	Shares	Value ($000)	Average Close	Price Range
Q1 2025	169,000	$8,173	$41.90	$33.70 - $60.60
Q4 2024	275,000	$10,615	$43.60	$33.31 - $48.89
Q1 2024	34,500	$998	$27.21	$21.43 - $33.34
Q4 2023	83,000	$1,903	$17.50	$13.72 - $23.88
Q2 2023	39,800	$1,099	$25.03	$17.64 - $30.10
Q4 2022	236,000	$2,575	$8.44	$7.24 - $11.46